Verastem Inc. (NASDAQ:VSTM) does about 5.52M shares in volume on a normal day but saw 4165748 shares change hands in Monday trading. The company now has a market cap of 203.89M USD and an enterprise value of about $147.88M. Its current market price is $1.26, marking a decrease of -4.55% compared to the previous close of $1.32. The 52 week high reached by this stock is $4.67 whilst the lowest price level in 52 weeks is $0.83. The script in recent trading has seen the stock touch a high of $1.34 and a low of $1.25.
Verastem Inc. (VSTM) has a 20-day trading average at $1.4155 and the current price is -73.02% off the 52-week high compared with 51.81% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.4883 and its 200-day simple moving average is $1.8513. If we look at the stock’s price movements over the week, volatility stands at 5.72%, which increases to 6.24% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 34.94 to suggest the stock is neutral.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 20, 2019 when BTIG Research downgraded the stock to “Neutral” and issued a price target of . Raymond James also downgraded the stock to “Mkt Perform” from Outperform on May 10, 2019 at a price target of . BTIG Research initiated its price target at $17.
The current price level is -11.49%, -15.95%, and -31.89% away from its SMA20, SMA50, and SMA200 respectively, with the VSTM price moving above the 50-day SMA on August 31. Verastem Inc. (VSTM) stock is down -3.08% over the week and -5.97% over the past month. Its price is -5.97% year-to-date and 0.00% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.14 above consensus estimates by $0.01. VSTM’s earnings per share are forecast to grow by 77.50% this year and 35.60% over next year. Expected sales for next quarter are $2.17 million, which analysts say will come at $37.76 million for the current fiscal year and next year at $17.38 million. In addition, estimates put the company’s current quarterly revenue at an average of $37.89 million.
Outstanding shares total 165.40M with insiders holding 6.72% of the shares and institutional holders owning 28.23% of the company’s common stock. The company has a return on investment of -119.40% and return on equity of -195.30%. The beta has a value of 0.96. Price to book ratio is 1.83 and price to sales ratio is 9.27.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has added its position in Verastem Inc. (VSTM) to 4,950,874 shares, mirroring a recent increase by 2.48%. Vanguard Total Stock Market Index added 0.12 million shares of Verastem Inc. common stock bringing its total worth to about $6.63 million at the end of recent close, SEC documents show. Vanguard Total Stock Market Index isn’t the only investment manager who changed stakes and is followed by iShares Russell 2000 ETF, which sold off -0.16 million shares to end up with 3,485,648 shares worth $4.67 million. Vanguard Extended Market Index Fu cut their holdings by -0.30% in the company over the course of the most recent quarter. It now holds a 1.24% position in Verastem Inc. thanks to 2.02 million shares amounting to $2.7 million.